Davidson Investment Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-201
Closed -$13K 220
2016
Q4
$13K Sell
201
-229
-53% -$14.9K ﹤0.01% 191
2016
Q3
$30K Buy
430
+28
+7% +$2.04K ﹤0.01% 141
2016
Q2
$28K Buy
402
+90
+29% +$6.22K ﹤0.01% 140
2016
Q1
$20K Buy
312
+200
+179% +$13.6K ﹤0.01% 186
2015
Q4
$8K Hold
112
﹤0.01% 204
2015
Q3
$9K Sell
112
-1,077
-91% -$95.9K ﹤0.01% 192
2015
Q2
$103K Buy
1,189
+1,077
+962% +$98.8K 0.02% 146
2015
Q1
$9K Buy
+112
New +$9.93K ﹤0.01% 176

Other funds holding NVS

Davidson Investment Advisors's NVS Position: Q1 2017 in Review

Davidson Investment Advisors sold out of Novartis (NVS) in Q1 2017, closing a stake of 201 shares — an estimated $13K sold.

Davidson Investment Advisors first reported a position in NVS in Q1 2015 and held it in 8 quarters. The position peaked at $103K in Q2 2015. 910 funds tracked by Wall St. Rank hold NVS as of Q1 2017.

  • Davidson Investment Advisors reported no remaining Novartis position as of Q1 2017 after selling out during the quarter.
  • Davidson Investment Advisors sold 201 Novartis shares in Q1 2017, an estimated $13K.
  • Davidson Investment Advisors first reported a position in Novartis in Q1 2015 and held it in 8 quarters.
  • Davidson Investment Advisors's Novartis position peaked at $103K in Q2 2015.
  • 910 funds tracked by Wall St. Rank held Novartis as of Q1 2017.

Based on Davidson Investment Advisors's 13F filing for Q1 2017, filed 12 May 2017.